InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.20) by 10 percent. This is a 4.76 percent decrease over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $1.53 million which beat the analyst consensus estimate of $1.45 million by 5.45 percent. This is a 1.19 percent increase over sales of $1.51 million the same period last year.